Forty Seven Inc. (NASDAQ:FTSV) +23% after-hours following a Bloomberg report that Gilead Sciences (NASDAQ:GILD) has approached the company with a takeover offer.
Gilead and Forty Seven are discussing several of
options including a partnership, according to the report, which adds
that Forty Seven also has received interest from other potential
suitors.
Forty Seven is working on cancer treatments that harness the immune system to fight tumors.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.